retatrutide type 2 diabetes trial 2024 clinical doses ESC 2024: improves lipid and cardiovascular risk profile in Phase II Tirzepatide vs. Retatrutide: Key Differences – retatrutide type 2 diabetes trial

US$ 22.55

★★★★★ 4.9 (18 reviews)

US$ 21.28

★★★★★ 4.2 (13 reviews)

US$ 24.71

★★★★★ 4.4 (18 reviews)

US$ 22.05

★★★★★ 4.4 (12 reviews)

US$ 24.12

★★★★★ 4.1 (22 reviews)

US$ 27.77

★★★★★ 4.1 (7 reviews)

US$ 23.13

★★★★★ 4.6 (23 reviews)

US$ 20.88

★★★★★ 4.8 (19 reviews)

US$ 20.73

★★★★★ 4.7 (16 reviews)

US$ 25.41

★★★★★ 4.4 (13 reviews)

US$ 22.95

★★★★★ 4.9 (10 reviews)

US$ 26.52

★★★★★ 4.1 (11 reviews)

US$ 21.67

★★★★★ 5.0 (11 reviews)

US$ 24.15

★★★★★ 4.5 (8 reviews)

US$ 26.75

★★★★★ 4.1 (22 reviews)

US$ 23.70

★★★★★ 4.0 (25 reviews)

US$ 22.22

★★★★★ 4.1 (25 reviews)

US$ 26.90

★★★★★ 4.3 (30 reviews)

US$ 29.60

★★★★★ 4.7 (29 reviews)

US$ 26.37

★★★★★ 4.2 (30 reviews)